Liping Li , Ph.D.

Department of Epidemiology

Research Achievements

Representative Publications (Last 5 Years):

• Li, L.#; Wu, H.#; Wang, J.#; Ji, Z.; Fang, T.; Lu, H.; Yan, L.; Shen, F.; Zhang, D.; Jiang, Y.; Ni, T. Discovery of novel 8-hydroxyquinoline derivatives with potent in vitro and in vivo antifungal activity. J. Med. Chem.2023, 66, 16364–16376.

• Li, L.#; Wu, H.#; Zhu, S.; Ji, Z.; Chi, X.; Xie, F.; Hao, Y.; Lu, H.; Yang, F.; Yan, L.; Zhang, D.; Jiang, Y.; Ni, T. Discovery of novel 7-hydroxy-5-oxo-4,5-dihydrothieno[3,2-b]pyridine-6-carboxamide derivatives with potent and selective antifungal activity against Cryptococcus species. J. Med. Chem.2022, 65, 11257–11269.

• Li, L.#; Lu, H.#; Zhang, X.; Whiteway, M.; Wu, H.; Tan, S.; Zang, J.; Tian, S.; Zhen, C.; Meng, X.; Li, W.; Zhang, D.; Zhang, M.; Jiang, Y. Baicalein acts against Candida albicans by targeting Eno1 and inhibiting glycolysis. Microbiol. Spectr.2022, e0208522.